Posterior uveal melanoma. Distribution of the sites of origin and patterns of tumour extent in the ocular fundus

British Journal of Ophthalmology

Volumn 92, Issue 6, 2008, Pages 751-756

  Krohn, J ^a,b   Froystein T ^b   Dahl, O ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRUCH MEMBRANE; CANCER LOCALIZATION; CANCER SIZE; CELL TYPE; COMPUTER; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; EYE FUNDUS; FEMALE; GEOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NOSE; PRIORITY JOURNAL; RETINA; SPINDLE CELL; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CHOROID NEOPLASMS; DATABASES, FACTUAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; OPHTHALMOSCOPY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 45249113043     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.133025     Document Type: Article

References (27)

1. Rones B, Zimmerman LE. The prognosis of primary tumors of the iris treated by iridectomy. AMA Arch Ophthalmol 1958;60:193-205.
2. Jensen OA. Malignant melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol (Copenh) 1970;48:1113-28.
3. Shields CL, Shields JA, Materin M, et al. Iris melanoma. Risk factors for metastasis in 169 consecutive patients. Ophthalmology 2001;108:172-8.
4. Li W, Judge H, Gragoudas ES, et al. Patterns of tumor initiation in choroidal melanoma. Cancer Res 2000;60:3757-60.
5. Schwartz LH, Ferrand R, Boelle PY, et al. Lack of correlation between the location of choroidal melanoma and ultraviolet radiation dose distribution. Radiat Res 1997;147:451-6.
6. Krohn J, Monge OR, Skorpen TN, et al. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. Eye. Published Online First 22 June 2007. doi:10.1038/sj.eye.6702911.
7. Jonas JB, Gusek GC, Naumann GOH. Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes. Invest Ophthalmol Vis Sci 1988;29:1151-8.
8. Straatsma BR, Landers MB, Kreiger AE, et al. Topography of the adult human retina. UCLA Forum Med Sci 1969;8:379-410.
9. UICC, International Union Against Cancer. TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. 3rd edn, 2nd rev. Berlin: Springer, 1992:300-6.
10. Collaborative Ocular Melanoma Study Group. Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study. COMS Report No. 21. Arch Ophthalmol 2003;121:1163-71.
11. Callender GR. Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931;36:131-42.
12. Astrahan MA, Luxton G, Pu Q, et al. Conformal episcleral plaque therapy. Int J Radiat Oncol Biol Phys 1997;39:505-19.
13. Knutsen S, Hafslund R, Monge OR, et al. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy. Int J Radiat Oncol Biol Phys 2001;51:1159-66.
14. Mosier MA. Retinal cartography. Can J Ophthalmol 1982;17:219-22.
15. Gündüz K, Shields CL, Shields JA, et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999;117:609-14.
16. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma. Long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol 2000;118:1219-28.
17. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119:969-82.
18. Shields CL, Naseripour M, Cater J, et al. Plaque radiotherapy for large posterior uveal melanomas (≥8-mm thick) in 354 consecutive patients. Ophthalmology 2002;109:1838-49.
19. Vjadic CM, Kricker A, Giblin M, et al. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer 2003;105:117-22.
20. Harbour JW, Brantley MA Jr, Hollingsworth H, et al. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol 2004;88:39-43.
21. Horn EP, Hartge P, Shields JA, et al. Sunlight and risk of uveal melanoma. J Natl Cancer Inst 1994;86:1476-8.
22. Shah CP, Weis E, Lajous M, et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma. A meta-analysis. Ophthalmology 2005;112:1599-607.
23. Singh AD, Rennie IG, Seregard S, et al. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 2004;49:419- 28.
24. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M. Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes. Am J Ophthalmol 1996;121:181-9.
25. Seregard S, Kock E. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand 1995;73:340-4.
26. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res 2001;11:255-63.
27. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977;95:63-9.